Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis
- PMID: 15766783
- DOI: 10.1016/j.femsle.2005.02.004
Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis
Abstract
Leptospirosis is an important global human and veterinary health problem. Humans can be infected by exposure to chronically infected animals and their environment. An important focus of the current leptospiral research is the identification of outer membrane proteins (OMPs). Due to their location, leptospiral OMPs are likely to be relevant in host-pathogen interactions, hence their potential ability to stimulate heterologous immunity. The existing whole-genome sequence of Leptospira interrogans serovar Copenhageni offers a unique opportunity to search for cell surface proteins. Predicted genes encoding potential surface proteins were amplified from genomic DNA by PCR methodology and cloned into an Escherichia coli expression system. The partially purified recombinant proteins were probed by Western blotting with sera from human patients diagnosed with leptospirosis. Sixteen proteins, out of a hundred tested, were recognized by antibodies present in human sera. Four of these proteins were conserved among eight serovars of L. interrogans and absent in the non-pathogenic Leptospira biflexa. These proteins might be useful for the diagnosis of the disease as well as potential vaccine candidates.
Similar articles
-
In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans.BMC Genomics. 2006 Nov 16;7:293. doi: 10.1186/1471-2164-7-293. BMC Genomics. 2006. PMID: 17109759 Free PMC article.
-
Molecular characterization of the pL40 protein in Leptospira interrogans.Can J Microbiol. 2009 Jun;55(6):739-49. doi: 10.1139/w09-014. Can J Microbiol. 2009. PMID: 19767845
-
Leptospiral immunoglobulin-like proteins elicit protective immunity.Vaccine. 2004 Mar 29;22(11-12):1545-52. doi: 10.1016/j.vaccine.2003.10.007. Vaccine. 2004. PMID: 15063580
-
Technological advances in the molecular biology of Leptospira.J Mol Microbiol Biotechnol. 2000 Oct;2(4):455-62. J Mol Microbiol Biotechnol. 2000. PMID: 11075918 Review.
-
Leptospirosis vaccines: past, present, and future.J Postgrad Med. 2005 Jul-Sep;51(3):210-4. J Postgrad Med. 2005. PMID: 16333195 Review.
Cited by
-
The leptospiral OmpA-like protein (Loa22) is a surface-exposed antigen that elicits bactericidal antibody against heterologous Leptospira.Vaccine X. 2023 Sep 1;15:100382. doi: 10.1016/j.jvacx.2023.100382. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37727366 Free PMC article.
-
MPL36, a major plasminogen (PLG) receptor in pathogenic Leptospira, has an essential role during infection.PLoS Pathog. 2023 Jul 24;19(7):e1011313. doi: 10.1371/journal.ppat.1011313. eCollection 2023 Jul. PLoS Pathog. 2023. PMID: 37486929 Free PMC article.
-
Use of an Integrated Multi-Omics Approach To Identify Molecular Mechanisms and Critical Factors Involved in the Pathogenesis of Leptospira.Microbiol Spectr. 2023 Feb 28;11(2):e0313522. doi: 10.1128/spectrum.03135-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36853003 Free PMC article.
-
Heterologous production of the adhesin LIC13411 from pathogenic Leptospira facilitates binding of non-pathogenic Leptospira in vitro and in vivo.Front Cell Infect Microbiol. 2022 Jul 22;12:917963. doi: 10.3389/fcimb.2022.917963. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35937702 Free PMC article.
-
Screening of Surface-Exposed Lipoproteins of Leptospira Involved in Modulation of Host Innate Immune Response.Front Microbiol. 2022 Mar 24;13:761670. doi: 10.3389/fmicb.2022.761670. eCollection 2022. Front Microbiol. 2022. PMID: 35401498 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
